FDA Drug Safety Surveillance Poses No Conflict Of Interest - Temple

FDA monitoring of drug safety poses no conflict of interest within the agency, Associate Director for Medical Policy Robert Temple, MD, maintained during a Food and Drug Law Institute conference Dec. 17 in response to a New England Journal of Medicine article calling for an independent board to monitor and evaluate drug safety.